Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Cavanagh
AddedFeb 15, 2024
UpdatedMay 31, 2026
Peter Cavanagh

Peter Cavanagh

Founder, JointMetrix Medical

CrunchbaseLinkedIn

Peter Cavanagh's Career

JointMetrix Medical
JointMetrix Medical

Seattle, WA, US

Founder
University of Washington
University of Washington

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Cavanagh's Career

JointMetrix Medical
JointMetrix Medical
Pre-Seed$500k52011Seattle, WA, US
Founder

Similar to JointMetrix Medical

MedicaMetrixMedicaMetrixLowell, MA, USMedical Devicesest. 2020MedicaMetrixLowell, MA, US · est. 2020

MedicaMetrix: Innovating patient care through transformative Med-tech solutions.

Seed · $7.4M38
VolumetrixVolumetrixNashville, TN, USHealthcare, Monitoringest. 2015VolumetrixNashville, TN, US · est. 2015

VoluMetrix: Innovating monitoring technologies for enhanced well-being, from hospital to home.

Series A · $3.3M12
Vital MetrixVital MetrixHuntsville, AL, USMedical Devicesest. 2013Vital MetrixHuntsville, AL, US · est. 2013

Vital Metrix: Innovating non-invasive, patented cardiac output measurement technology.

Seed · $460k30
Cymedica OrthopedicsCymedica OrthopedicsScottsdale, AZ, USMedical Devicesest. 2013Cymedica OrthopedicsScottsdale, AZ, US · est. 2013

CyMedica: Innovating products for joint injuries and muscle atrophy.

Seed · $27.6M9
University of Washington
University of Washington
GovernmentGovernment$123.9M16.2k1861Seattle, WA, US
Board Member· Board

Recent news

Anthropic acquires computer-use AI startup Vercept after Meta poached one of its foundersTechCrunch · 2026
Step aside, Zoom fatigue, VRTL wants to make virtual fan events fun againTechCrunch · 2024

Leadership at University of Washington

Greg NewbloomGreg NewbloomCo-Founder
Ana Mari CauceAna Mari CauceBoard Member
Trisha DavisTrisha DavisBoard Member
Paul MoultonPaul MoultonBoard Member
Jurgen UnutzerJurgen UnutzerBoard Member
Payman ArabshahiPayman ArabshahiBoard Member

Peter Cavanagh's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Peter Cavanagh

Barry LutzBarry LutzCo-Founder · Aqueduct Critical CareWarren BoekerWarren BoekerBoard Member · University of WashingtonDing YuanDing YuanBoard Member · University of TorontoMija HublerMija HublerCo-Founder · Prometheus MaterialsAleksander S. PopelAleksander S. PopelCo-Founder · AsclepiX TherapeuticsAbbas RajabifardAbbas RajabifardBoard Member · University of Melbourne